NMNAT3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Products
Nmnat3 (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
qSTAR qPCR primer pairs against Homo sapiens gene NMNAT3
Nmnat3 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Nmnat3 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Nmnat3 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
NMNAT3 Rabbit polyclonal Antibody
| Applications | ELISA, ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Unmodified |
NMNAT3 Rabbit polyclonal Antibody
| Applications | ELISA, ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Unmodified |
NMNAT3 Rabbit polyclonal antibody
| Applications | IHC, WB |
| Reactivities | Mouse, Human |
Goat Anti-Nmnat3 (mouse) Antibody
| Applications | WB |
| Reactivities | Mouse |
NMNAT3 Antibody - N-terminal region
| Applications | WB |
| Reactivities | Human |
NMNAT3 (tGFP-tagged) - Human nicotinamide nucleotide adenylyltransferase 3 (NMNAT3), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
NMNAT3 (tGFP-tagged) - Homo sapiens nicotinamide nucleotide adenylyltransferase 3 (NMNAT3), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Nmnat3 (tGFP-tagged) - Mouse nicotinamide nucleotide adenylyltransferase 3 (Nmnat3)
| Type | Mouse Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
